IP Library Granted Patent US 12,220,305
Granted Patent B2
US 12,220,305 · App. 17/179,746 · Granted Feb 11, 2025

Systems and methods for transcatheter aortic valve treatment

Inventors: Erica J. Rogers (Sunnyvale, CA); Michael P. Wallace (Sunnyvale, CA); Sumaira Macdonald (Sunnyvale, CA); Michi E. Garrison (Sunnyvale, CA)
Assignee: Silk Road Medical, Inc.
A61F2/013A61F2/2436A61F2002/016A61F2230/0067A61F2230/0069A61F2230/0093A61M2025/0681
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,220,305
App. No.
17/179,746
Granted
Feb 11, 2025
Kind
B2
Abstract

Devices and methods are configured to allow transcarotid or subclavian access via the common carotid artery to the native aortic valve, and implantation of a prosthetic aortic valve into the heart. The devices and methods also provide means for embolic protection during such an endovascular aortic valve implantation procedure.

Claims (20)

1. A system for transcatheter aortic valve treatment, comprising:

an arterial access sheath adapted to be introduced into an access site at the left or right carotid artery, or left or right subclavian artery,

wherein the arterial access sheath has a first lumen configured to receive a valve delivery system, the valve delivery system configured to deliver a prosthetic valve into a heart or aorta through the arterial access sheath, the first lumen having a first opening at a proximal end of the arterial access sheath and a distal opening at a distal most end of the arterial access sheath;

wherein the arterial access sheath further has a perfusion lumen with a proximal end and a distal opening and wherein the perfusion lumen has a length such that the distal opening of the perfusion lumen can be positioned in and perfuse an artery when in use;

an elongated body having a shunt lumen, the elongated body configured to fluidly connect an external source of perfusion fluid to the perfusion lumen of the arterial access sheath, wherein the elongated body receives perfusion fluid only from a source of perfusion fluid other than the arterial access sheath; and

the valve delivery system, wherein the valve delivery system fits within the first lumen of the arterial access sheath.

2. A system as in claim 1 , wherein the distal opening of the perfusion lumen has a radiopaque marker.

3. A system as in claim 1 , wherein the arterial blood source comprises a sheath in a femoral artery.

4. A system as in claim 1 , wherein the shunt incorporates an active pump.

5. A system as in claim 1 , wherein the shunt further comprises an in-line filter.

6. A system as in claim 1 , wherein the access sheath further comprises an occlusion balloon at a distal end of the access sheath.

7. A system as in claim 1 , wherein the shunt does not include a filter.

8. A system as in claim 1 , wherein the artery that is perfused is the carotid artery.

9. A system as in claim 1 , wherein the proximal end of the first lumen has a proximal connector with a hemostasis valve and a Y-arm, and wherein the hemostasis valve is sized to fit therethrough the valve delivery system.

10. A system as in claim 1 , wherein the valve delivery system includes:

an inner shaft;

an outer sleeve co-axially aligned with the inner shaft and slidably positioned over the inner shaft;

a prosthetic aortic valve removably mounted on the inner shaft; and

an actuator coupled to the outer shaft, wherein the actuator can be actuated to retract the outer shaft from a first position to a second position that exposes the prosthetic aortic valve.

11. A system as in claim 10 , wherein the valve delivery system has an entire length between 45 cm and 60 cm.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2025
From: SILK ROAD MEDICAL, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 070671/0426 →
RELEASE OF SECURITY INTEREST Recorded Sep 17, 2024
From: OXFORD FINANCE, LLC
To: SILK ROAD MEDICAL, INC.
Reel/Frame 068979/0196 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2024
From: ROGERS, ERICA J.; WALLACE, MICHAEL P.; MACDONALD, SUMAIRA; GARRISON, MICHI E.
To: SILK ROAD MEDICAL, INC.
Reel/Frame 067008/0311 →
SECURITY INTEREST Recorded Jul 11, 2023
From: SILK ROAD MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 064252/0197 →
Continuity (4)
Continuation 15141060 · Apr 28, 2016
Provisional Application 62210919 · Aug 27, 2015
Provisional Application 62155384 · Apr 30, 2015
Related Publication 20210244522A1 · Aug 12, 2021
References Cited (131)
US 4540402A · Aigner · 1985 [cited by applicant]
US 4808156A · Dean · 1989 [cited by applicant]
US 6413235B1 · Parodi · 2002 [cited by applicant]
US 6423032B2 · Parodi · 2002 [cited by applicant]
US 6454799B1 · Schreck · 2002 [cited by applicant]
US 6514226B1 · Levin et al. · 2003 [cited by applicant]
US 6595953B1 · Coppi et al. · 2003 [cited by applicant]
US 6837881B1 · Barbut · 2005 [cited by applicant]
US 6866650B2 · Stevens et al. · 2005 [cited by applicant]
US 7083594B2 · Coppi · 2006 [cited by applicant]
US 7491163B2 · Viole et al. · 2009 [cited by applicant]
US 8298169B2 · Yacoubian et al. · 2012 [cited by applicant]
US 8460335B2 · Carpenter · 2013 [cited by applicant]
US 8545432B2 · Renati et al. · 2013 [cited by applicant]
US 8858490B2 · Chou · 2014 [cited by examiner]
US 9126018B1 · Garrison · 2015 [cited by examiner]
US 9241699B1 · Kume et al. · 2016 [cited by applicant]
US 10039906B2 · Kume et al. · 2018 [cited by applicant]
US 10085864B2 · Chou et al. · 2018 [cited by applicant]
US 10159479B2 · Hentges et al. · 2018 [cited by applicant]
US 10925709B2 · Rogers · 2021 [cited by examiner]
US 11433226B2 · Kume · 2022 [cited by examiner]
US 11844893B2 · Drake · 2023 [cited by examiner]
US 12070542B2 · McCarthy · 2024 [cited by examiner]
US 20020049402A1 · Peacock et al. · 2002 [cited by applicant]
US 20020128679A1 · Turovskiy et al. · 2002 [cited by applicant]
US 20050154344A1 · Chang · 2005 [cited by applicant]
US 20050154349A1 · Renz et al. · 2005 [cited by applicant]
US 20050245892A1 · Elkins et al. · 2005 [cited by applicant]
US 20060106338A1 · Chang · 2006 [cited by applicant]
US 20090018455A1 · Chang · 2009 [cited by applicant]
US 20090024072A1 · Criado et al. · 2009 [cited by applicant]
US 20090198172A1 · Garrison et al. · 2009 [cited by applicant]
US 20090240320A1 · Tuval et al. · 2009 [cited by applicant]
US 20090254166A1 · Chou et al. · 2009 [cited by applicant]
US 20100042118A1 · Garrison et al. · 2010 [cited by applicant]
US 20100057096A1 · Wolf · 2010 [cited by applicant]
US 20100185216A1 · Garrison et al. · 2010 [cited by applicant]
US 20100191169A1 · Chang · 2010 [cited by applicant]
US 20100191170A1 · Chang · 2010 [cited by applicant]
US 20100204684A1 · Garrison et al. · 2010 [cited by applicant]
US 20100217276A1 · Garrison et al. · 2010 [cited by applicant]
US 20100228269A1 · Garrison et al. · 2010 [cited by applicant]
US 20100280431A1 · Criado et al. · 2010 [cited by applicant]
US 20110082408A1 · Chang · 2011 [cited by applicant]
US 20110087147A1 · Garrison et al. · 2011 [cited by applicant]
US 20110125131A1 · Chang · 2011 [cited by applicant]
US 20110144690A1 · Bishop et al. · 2011 [cited by applicant]
US 20110166496A1 · Criado et al. · 2011 [cited by applicant]
US 20110166497A1 · Criado et al. · 2011 [cited by applicant]
US 20110213459A1 · Garrison · 2011 [cited by examiner]
US 20130172852A1 · Chang · 2013 [cited by applicant]
US 20130197621A1 · Ryan et al. · 2013 [cited by applicant]
US 20130281788A1 · Garrison · 2013 [cited by examiner]
US 20140031682A1 · Renati et al. · 2014 [cited by applicant]
US 20140031925A1 · Garrison et al. · 2014 [cited by applicant]
US 20140058414A1 · Garrison et al. · 2014 [cited by applicant]
US 20140135661A1 · Garrison · 2014 [cited by examiner]
US 20140296769A1 · Hyde · 2014 [cited by examiner]
US 20140296868A1 · Garrison et al. · 2014 [cited by applicant]
US 20140371653A1 · Criado et al. · 2014 [cited by applicant]
US 20150025616A1 · Chang · 2015 [cited by applicant]
US 20150080942A1 · Garrison et al. · 2015 [cited by applicant]
US 20150141760A1 · Chou et al. · 2015 [cited by applicant]
US 20150150562A1 · Chang · 2015 [cited by applicant]
US 20150174368A1 · Garrison · 2015 [cited by examiner]
US 20150327843A1 · Garrison · 2015 [cited by applicant]
US 20160128688A1 · Garrison et al. · 2016 [cited by applicant]
US 20160158044A1 · Chou et al. · 2016 [cited by applicant]
US 20160158502A1 · Kume et al. · 2016 [cited by applicant]
US 20160166804A1 · Garrison et al. · 2016 [cited by applicant]
US 20160242764A1 · Garrison et al. · 2016 [cited by applicant]
US 20160271315A1 · Chang · 2016 [cited by applicant]
US 20160271316A1 · Criado et al. · 2016 [cited by applicant]
US 20160279379A1 · Chang · 2016 [cited by applicant]
US 20160296690A1 · Kume · 2016 [cited by examiner]
US 20160317288A1 · Rogers · 2016 [cited by examiner]
US 20170043141A1 · Kume et al. · 2017 [cited by applicant]
US 20170136212A1 · Garrison et al. · 2017 [cited by applicant]
US 20170209260A1 · Garrison et al. · 2017 [cited by applicant]
US 20170296798A1 · Kume et al. · 2017 [cited by applicant]
US 20170312491A1 · Ryan et al. · 2017 [cited by applicant]
US 20170354803A1 · Kume et al. · 2017 [cited by applicant]
US 20170361072A1 · Chou et al. · 2017 [cited by applicant]
US 20170368296A1 · Chang · 2017 [cited by applicant]
US 20180008294A1 · Garrison et al. · 2018 [cited by applicant]
US 20180154063A1 · Criado et al. · 2018 [cited by applicant]
US 20180185614A1 · Garrison et al. · 2018 [cited by applicant]
US 20180289884A1 · Criado et al. · 2018 [cited by applicant]
US 20190105439A1 · Criado et al. · 2019 [cited by applicant]
US 20190150916A1 · Hentges et al. · 2019 [cited by applicant]
US 20190175885A1 · Kume et al. · 2019 [cited by applicant]
US 20190231962A1 · Criado et al. · 2019 [cited by applicant]
US 20190254680A1 · Chang · 2019 [cited by applicant]
US 20190262530A1 · Criado et al. · 2019 [cited by applicant]
US 20190269538A1 · Chou et al. · 2019 [cited by applicant]
US 20190366070A1 · Kume et al. · 2019 [cited by applicant]
US 20190388654A1 · Chou et al. · 2019 [cited by applicant]
US 20200009406A1 · Garrison et al. · 2020 [cited by applicant]
US 20200015826A1 · Chang · 2020 [cited by applicant]
US 20200016321A1 · Criado et al. · 2020 [cited by applicant]
US 20210244522A1 · Rogers · 2021 [cited by examiner]
CN 103826571A · 2014 [cited by applicant]
CN 104582643A · 2015 [cited by applicant]
JP 2011507597A · 2011 [cited by applicant]
JP 2014524813A · 2014 [cited by applicant]
WO WO2009085207A1 · 2009 [cited by applicant]
WO WO2013013021A2 · 2013 [cited by applicant]
Henry et al. (1999) “Carotid stenting with cerebral protection: First clinical experience using the PercuSurge GuardWire System” J. Endovasc. Surg. 6:321-331. [cited by applicant]
U.S. Appl. No. 14/227,585, filed Mar. 27, 2014, US 2014-0296769. [cited by applicant]
U.S. Appl. No. 15/049,637, filed Feb. 22, 2016, US 2016-0242764. [cited by applicant]
U.S. Appl. No. 15/399,638, filed Jan. 5, 2017, US 2017-0209260. [cited by applicant]
U.S. Appl. No. 15/641,966, filed Jul. 5, 2017, US 2017-0296798. [cited by applicant]
U.S. Appl. No. 16/171,784, filed Oct. 26, 2018, US 2019-0125512. [cited by applicant]
U.S. Appl. No. 16/281,311, filed Feb. 21, 2019, US 2019-0388654. [cited by applicant]
U.S. Appl. No. 16/297,348, filed Mar. 8, 2019, US 2020-0038576. [cited by applicant]
U.S. Appl. No. 16/299,524, filed Mar. 12, 2019, US 2019-0366070. [cited by applicant]
U.S. Appl. No. 16/353,492, filed Mar. 14, 2019, US 2020-0009406. [cited by applicant]
U.S. Appl. No. 16/377,663, filed Apr. 8, 2019, US 2019-0231962. [cited by applicant]
U.S. Appl. No. 16/513,030, filed Jul. 16, 2019, US 2020-0170637. [cited by applicant]
U.S. Appl. No. 16/530,783, filed Aug. 2, 2019, US 2020-0054871. [cited by applicant]
U.S. Appl. No. 16/544,083, filed Aug. 19, 2019, US 2020-0171277. [cited by applicant]
U.S. Appl. No. 16/880,594, filed May 21, 2020, US 2020-0282127. [cited by applicant]
U.S. Appl. No. 16/894,474, filed Jun. 5, 2020, US 2020-0297912. [cited by applicant]
U.S. Appl. No. 16/906,457, filed Jun. 19, 2020, US 2020-0397472. [cited by applicant]
U.S. Appl. No. 16/939,396, filed Jul. 27, 2020, US 2020-0397446. [cited by applicant]
U.S. Appl. No. 16/999,634, filed Aug. 21, 2020, US 2020-0375728. [cited by applicant]
U.S. Appl. No. 16/999,640, filed Aug. 21, 2020, US 2020-0375729. [cited by applicant]
U.S. Appl. No. 17/000,004, filed Aug. 21, 2020, US 2020-0390437. [cited by applicant]
PCT/US2020/058365, Oct. 30, 2020, WO 2021/087363. [cited by applicant]
PCT/US2020/058588, Nov. 2, 2020, WO 2021/087470. [cited by applicant]